Feature | October 30, 2008| Nick Obradovich

Is Coronary MR Angiography Ready for Prime Time?

Despite some key advantages, MRA is not yet expected to overtake coronary CTA.

The University of Virginia Health System uses a Siemens MAGNETOM Avanto 1.5T MRI system.

The University of Virginia Health System uses a Siemens MAGNETOM Avanto 1.5T MRI system.

"Potential” can be a loaded word, especially in healthcare. Many clinicians have tagged coronary MR angiography (MRA) with the “potential” label. Despite the scan’s reported safety advantages over coronary CT angiography (CTA), as well as its superior physiologic information, coronary MRA has not gained the widespread acceptance of coronary CTA.

Yet, many clinicians are hopeful the scan will gain momentum in the coming years as new techniques and new hardware/software progress.

What is the Potential?

Many cardiologists and radiologists are excited about the potential for coronary MRA to evaluate plaque. MR has been able to see and evaluate plaque for years in the carotid, aortic and peripheral arteries, according to Warren Manning, M.D., professor of radiology at Harvard Medical School, member of the cardiovascular disease department at Beth Israel Deaconess Medical Center in Boston. However, this potential has not led to significant clinical applications for coronary MRA for a large patient population.

“Plaque in coronary arteries is far more complicated in the MR,” Dr. Manning said. “The coronary wall is even smaller than the coronary lumen, so the burdens are more strict with motion compensation. There are techniques using gadolinium looking at inflammation in the wall of the arteries.

“CT looks at the anatomy. Is there a calcified plaque or a soft plaque? MR is looking for any plaque or if there is inflammation in the wall. We think inflammation probably means someone is at an increased risk for plaque rupture, but at the present time it’s just a hypothesis. We don’t really know for sure that MRI can identify the sites where plaque will rupture. All of this for [MR] coronary plaque imaging is really in the research arena at the present time.”

Safety, Imaging Advantages

Currently, coronary MRA’s primary advantage over CTA is that it doesn’t use radiation or iodinated contrast material.
“One of the issues that often comes up is if patients are going to need repeated studies,” Dr. Manning said. “Repeated studies in the CT world mean repeated exposure to radiation. There are no such issues with MR.”

Many doctors, as well as parents, are hesitant to expose children to radiation from a CT scan. For this reason, coronary MRA is preferred for younger patients being imaged for anomalous coronary artery disease, according to an American Heart Association Scientific Statement released in July.

“If one isn’t trying to discriminate ischemic versus non-ischemic cardiomyopathies, then I think both MR and CT work, and we’d say that MR may be preferred in that group as well,” Dr. Manning said.

Coronary MRA doesn’t typically use contrast, while CTA uses iodine-based contrast materials that can be problematic for patients with renal insufficiencies.

The scan also holds advantages over CTA in that it doesn’t require a slow heartbeat and it images calcium better. Heavily calcified arteries are a burden for CTA. However, in part because the MR allows for free breathing, a coronary MRA has an acquisition time of 5-10 minutes, as opposed to less than 20 seconds for a CTA.

Spatial Resolution vs. CTA

The major drawback to coronary MRA is the inferior spatial resolution, according to Christopher M. Kramer, M.D., professor of radiology and medicine, director of cardiovascular imaging, University of Virginia Health System.

“Because CT has higher spatial resolution and has performed better for stenosis detection, CTA is preferable,” Dr. Kramer said. “For many other cardiac applications, MR is preferable. In 2008, for assessment of coronary artery disease in a middle- aged or older patient, CT is probably preferable.”

Dr. Manning believes that although CTA has better spatial resolution, a coronary MRI scan is still very readable.

“If you have experience [in reading both scans], then I think the interpretation is similar,” Dr. Manning said. “I think there are more 64-slice CT scanners in existence than there are MR sites that have experience in coronary MRI. People need to consider their local expertise like every other imaging or procedural modality.”

Coronary MRI has improved in recent years, according to Dr. Kramer, who has used Siemens’ MAGNETOM Avanto 1.5T MRI system since 2004.

“The major improvements have been the use of 3D coronary imaging,” Dr. Kramer said. “This is a 3D whole-heart approach where a navigator is used to track diaphragmatic motion and capture the 3D image of the heart over many heart beats. It’s respiratory-gated using navigator echoes. The improvement in the navigators has also helped image quality.”

Dr. Manning, who uses a Philips 1.5T MRI system, also noted scanners have moved from 16 to 32 channel coils, which helps with signal-to-noise ratios.

New Technology, Techniques

There is no shortage of ways in which clinicians are looking to improve spatial resolution to help coronary MRA reach its potential.

“Going to 3 Tesla has the potential to improve image quality and spatial resolution for certain applications,” Dr. Kramer said. “Coronary imaging is one of them. There’s certainly more data coming out now with whole-heart coronary angiography MR at 3T. I think the performance will be better than at 1.5T, but still not to CTA spatial resolution.”

Dr. Manning noted than MR can yield better results without having a hardware upgrade.

“MR advances are very much software-based,” Dr. Manning said. “New algorithms to do something. New sequences. But, you’re still using the same 1.5T or 3T scanner. That’s another advantage of MR.”

Other solutions to the spatial resolution problem include using a gadolinium-based contrast for the coronaries, using an intravascular MRI or developing the scan on higher field MR system.

“There is some work on intravascular MRI, but that’s invasive and not useful for a general patient population screening,” Dr. Kramer said. “There are 7T scanners scattered around the world, but there are a lot of issues to be tackled when you go to that high of a field.

“There is a potential to use MR contrast in imaging the coronary arteries,” he said. “It’s a little difficult because it’s a long acquisition, so the timing of contrast infusion relative to the acquisition of the images is tricky, but it may enhance coronary imaging.”

Related Content

Apollo Enterprise Imaging, DiACardio, Enterprise Patient Multimedia Manager, EPMM, LVivo Toolbox
Technology | Clinical Decision Support| January 19, 2017
January 19, 2017 — Apollo Enterprise Imaging Corp.
Technology | Radiation Dose Management| January 19, 2017
Zetta Medical Technologies announced the release of Zia, an iterative reconstruction solution that enables the use of...
MD Buyline, James Laskaris, four medical technology innovations, very near future
Feature | Cardiac Imaging| January 17, 2017
James Laskaris, emerging technology analyst at MD Buyline, recently offered his perspective on new medical technology...
PET/CT, atherosclerotic plaque detection, Stanford University

Application of dual-modality optical and PET/CT activity-based probe in experimental carotid inflammation model. Coronal noninvasive PET/CT scans of (A) healthy and (B) diseased mice with and without ligated carotid arteries respectively. Inset images show optical ex vivo florescence imagining of (A) healthy and (B) diseased carotid arteries.  PET/CT and optical images courtesy of Xiaowei Ma, Toshinobu Saito and Nimali Withana.

News | PET-CT| November 01, 2016
Researchers at Stanford University have demonstrated for the first time the use of a dual optical and positron emission...
GE Healthcare, Revolution CT, Whisper Drive, RSNA 2016, cardiac imaging
News | CT Angiography (CTA)| October 31, 2016
At the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), GE Healthcare will introduce the...
Philips, Lumify smart-device ultrasound, S4-1 cardiac transducer, RSNA 2016
Technology | Cardiovascular Ultrasound| October 14, 2016
Philips announced at The American College of Emergency Physicians' (ACEP) annual meeting that it has received 510(k)...
Toshiba CT, picking a CT scanner, choosing a CT scanner, CT 101, what to look for in CT scanners, Aquilion ONE ViSION

The Toshiba Aquilion One Vision system is among the new generation of CT systems on the market that offers several dose lowering technologies and a hardware/software combination to enhance image quality over previous-generation scanners.

Feature | CT Angiography (CTA)| October 14, 2016 | Dave Fornell
As hospitals begin replacing their first-generation 64-slice computed tomography (CT) scanners after a decade of use,
Medtronic, FDA approval, MRI, MR-conditional scanning, cardiac devices
Technology | EP Lab| October 13, 2016
Medtronic plc is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac...
Toshiba America Medical Systems, Infinix-i Sky + double sliding C-arm, RSNA 2016
Technology | Angiography| October 05, 2016
Interventional labs now have an imaging system that provides clinicians flexibility to perform a wide array of...
Infinix 4D CT

Toshiba's Infinix 4D CT, which combines CT with angiography in the interventional lab.

Feature | Angiography| September 28, 2016 | Tom Watson BS, RCVT, Clinical Analyst, MD Buyline
One of the more significant advancements for interventional X-ray (IXR) in the past few years has been a significantl
Overlay Init